Literature DB >> 21305526

Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis.

Matthew R Evans1, Agustín Escalante, Daniel F Battafarano, Gregory L Freeman, Daniel H O'Leary, Inmaculada del Rincón.   

Abstract

OBJECTIVE: The role of atherosclerosis in the acute coronary syndromes (ACS) that occur in patients with rheumatoid arthritis (RA) has not been quantified in detail. We undertook this study to determine the extent to which ACS are associated with carotid atherosclerosis in RA.
METHODS: We prospectively ascertained ACS, defined as myocardial infarction, unstable angina, cardiac arrest, or death due to ischemic heart disease, in an RA cohort. We measured carotid atherosclerosis using high-resolution ultrasound. We used Cox proportional hazards models to estimate the association between ACS and atherosclerosis, adjusting for demographic features, cardiovascular (CV) risk factors, and RA manifestations.
RESULTS: We performed carotid ultrasound on 636 patients whom we followed up for 3,402 person-years. During this time, 84 patients experienced 121 new or recurrent ACS events, a rate of 3.5 ACS events per 100 patient-years (95% confidence interval [95% CI] 3.0-4.3). Among the 599 patients without a history of ACS, 66 incident ACS events occurred over 3,085 person-years, an incidence of 2.1 ACS events per 100 person-years (95% CI 1.7-2.7). The incidence of new ACS events per 100 patient-years was 1.1 (95% CI 0.6-1.7) among patients without plaque, 2.5 (95% CI 1.7-3.8) among patients with unilateral plaque, and 4.3 (95% CI 2.9-6.3) among patients with bilateral plaque. Covariates associated with incident ACS events independent of atherosclerosis included male sex, diabetes mellitus, and a cumulative glucocorticoid dose of ≥ 20 gm.
CONCLUSION: Atherosclerosis is strongly associated with ACS in RA. RA patients with carotid plaque, multiple CV risk factors (particularly diabetes mellitus or hypertension), many swollen joints, and a high cumulative dose of glucocorticoids, as well as RA patients who are men, are at high risk of ACS.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2011        PMID: 21305526      PMCID: PMC3286362          DOI: 10.1002/art.30265

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  49 in total

1.  A tale of two diseases: atherosclerosis and rheumatoid arthritis.

Authors:  V Pasceri; E T Yeh
Journal:  Circulation       Date:  1999-11-23       Impact factor: 29.690

2.  ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).

Authors:  E Braunwald; E M Antman; J W Beasley; R M Califf; M D Cheitlin; J S Hochman; R H Jones; D Kereiakes; J Kupersmith; T N Levin; C J Pepine; J W Schaeffer; E E Smith; D E Steward; P Theroux; R J Gibbons; J S Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

3.  Brachial endothelial function is impaired in patients with systemic lupus erythematosus.

Authors:  Domingos S N Lima; Emilia I Sato; Valter C Lima; Fausto Miranda; Francisca H Hatta
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

4.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

5.  Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

Authors:  C Tetta; G Camussi; V Modena; C Di Vittorio; C Baglioni
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

6.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

7.  Cardiovascular mortality in patients with rheumatoid arthritis.

Authors:  O Mutru; M Laakso; H Isomäki; K Koota
Journal:  Cardiology       Date:  1989       Impact factor: 1.869

8.  Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications.

Authors:  A J Geirsson; G Sturfelt; L Truedsson
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

9.  Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

Authors:  T Saxne; M A Palladino; D Heinegård; N Talal; F A Wollheim
Journal:  Arthritis Rheum       Date:  1988-08

10.  Survival, prognosis, and causes of death in rheumatoid arthritis.

Authors:  D M Mitchell; P W Spitz; D Y Young; D A Bloch; D J McShane; J F Fries
Journal:  Arthritis Rheum       Date:  1986-06
View more
  49 in total

Review 1.  Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis.

Authors:  Silvio Romano; Elisa Salustri; Piero Ruscitti; Francesco Carubbi; Maria Penco; Roberto Giacomelli
Journal:  Curr Rheumatol Rep       Date:  2018-11-05       Impact factor: 4.592

Review 2.  Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.

Authors:  Anne Grete Semb; Eirik Ikdahl; Grunde Wibetoe; Cynthia Crowson; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2020-06-03       Impact factor: 20.543

3.  Carotid artery intima-media thickness in patients with autoimmune connective tissue diseases: a case-control study.

Authors:  Vincenzo Bruzzese; Cinzia Marrese; Angelo Zullo; Cesare Hassan; Lorenzo Ridola; Annamaria Izzo; Camillo Riccioni
Journal:  Intern Emerg Med       Date:  2011-10-28       Impact factor: 3.397

4.  Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis.

Authors:  Jon T Giles; Wendy S Post; Roger S Blumenthal; Joseph Polak; Michelle Petri; Allan C Gelber; Moyses Szklo; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2011-11

Review 5.  Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.

Authors:  Justin C Mason; Peter Libby
Journal:  Eur Heart J       Date:  2014-11-27       Impact factor: 29.983

6.  The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores.

Authors:  Vivian K Kawai; Cecilia P Chung; Joseph F Solus; Annette Oeser; Paolo Raggi; C Michael Stein
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

7.  Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis.

Authors:  Miguel A González-Gay; Carlos González-Juanatey
Journal:  Arthritis Res Ther       Date:  2012-03-12       Impact factor: 5.156

Review 8.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 9.  Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis.

Authors:  Antongiulio Scarno; Fabio Massimo Perrotta; Francesca Cardini; Alessia Carboni; Gianmarco Annibali; Ennio Lubrano; Antonio Spadaro
Journal:  World J Orthop       Date:  2014-07-18

10.  Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; Yuen Yin Lee; Ani Shahbazian; Alan H Gorn; John Fitzgerald; Veena K Ranganath; Mihaela Taylor; Nagesh Ragavendra; Maureen McMahon; David Elashoff; Srinivasa T Reddy
Journal:  Arthritis Rheum       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.